文献速递肝病消化道肿瘤与早癌

生长因子受体结合蛋白14抑制触发胰岛素诱导的小鼠肝细胞增殖并与肝细胞癌相关

Growth factor receptor binding protein 14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma.
PubMed 文献 · Hepatology · 2017-02-21

研究在小鼠中采用短发夹RNA策略抑制肝脏Grb14表达,发现胰岛素信号增强伴静息肝细胞短暂进入S期,原代细胞培养亦见增殖,且该过程依赖胰岛素受体及mTORC1-S6K通路和E2F1。85例人肝细胞癌中60%肿瘤Grb14 mRNA水平降低,显著低于癌旁非肿瘤肝组织。结论认为Grb14是肝脏胰岛素促有丝分裂作用的生理抑制因子,胰岛素信号失调与肝细胞癌相关。

要点

  • 小鼠肝脏Grb14抑制后胰岛素信号增强,静息肝细胞短暂进入S期。
  • Grb14缺失肝细胞增殖为细胞自主性,原代培养中同样观察到。
  • 85例人肝细胞癌中60%肿瘤Grb14 mRNA降低,显著低于癌旁组织。

核心结论

  • 本研究确立Grb14为肝脏胰岛素促有丝分裂作用的生理抑制因子,并进一步支持胰岛素信号失调与肝细胞癌相关。

研究设计与样本

  • 研究采用短发夹RNA策略在小鼠中特异性抑制肝脏Grb14表达,并检测肝细胞增殖。
  • 研究使用药理学方法和遗传小鼠模型联合Grb14下调与胰岛素信号阻断。
  • 研究检测了85例人肝细胞癌及其癌旁非肿瘤肝组织的GRB14表达。

主要发现

  • Grb14抑制后胰岛素信号增强,伴随静息肝细胞短暂进入S期。
  • Grb14缺陷肝细胞的增殖为细胞自主性,原代细胞培养中同样观察到。
  • Grb14抑制介导的肝细胞分裂涉及胰岛素受体激活,并由mTORC1-S6K通路和转录因子E2F1介导。
  • 85例人肝细胞癌中60%肿瘤Grb14 mRNA水平降低,肿瘤组织GRB14表达较癌旁非肿瘤肝组织显著且频繁降低。

关键数值与推荐

  • 85例人肝细胞癌中60%的肿瘤显示Grb14 mRNA水平降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Metabolic diseases such as obesity and type 2 diabetes are recognized as independent risk factors for hepatocellular carcinoma (HCC). Hyperinsulinemia, a hallmark of these pathologies, is suspected to be involved in HCC development. The molecular adapter growth factor receptor binding protein 14 (Grb14) is an inhibitor of insulin receptor catalytic activity, highly expressed in the liver. To study its involvement in hepatocyte proliferation, we specifically inhibited its liver expression using a short hairpin RNA strategy in mice. Enhanced insulin signaling upon Grb14 inhibition was accompanied by a transient induction of S-phase entrance by quiescent hepatocytes, indicating that Grb14 is a potent repressor of cell division. The proliferation of Grb14-deficient hepatocytes was cell-autonomous as it was also observed in primary cell cultures. Combined Grb14 down-regulation and insulin signaling blockade using pharmacological approaches as well as genetic mouse models demonstrated that Grb14 inhibition-mediated hepatocyte division involved insulin receptor activation and was mediated by the mechanistic target of rapamycin complex 1-S6K pathway and the transcription factor E2F1. In order to determine a potential dysregulation in GRB14 gene expression in human pathophysiology, a collection of 85 human HCCs was investigated. This revealed a highly significant and frequent decrease in GRB14 expression in hepatic tumors when compared to adjacent nontumoral parenchyma, with 60% of the tumors exhibiting a reduced Grb14 mRNA level. CONCLUSION: Our study establishes Grb14 as a physiological repressor of insulin mitogenic action in the liver and further supports that dysregulation of insulin signaling is associated with HCC. (Hepatology 2017;65:1352-1368).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Morzyglod L, Caüzac M, Popineau L, et al. Growth factor receptor binding protein 14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma. Hepatology. 2017. PMID: 27981611. doi:10.1002/hep.28972

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。